FIELD: medicine; prophylaxis and treatment of diseases associated with immunity disturbances. SUBSTANCE: immunimodulating agent is constituted by tris-(2-hydroxyethyl)ammonium indolyl-3-thioacetate. Preparation is water-soluble, highly active and nontoxic. It possesses well pronounced T-lymphotropic effect, while exhibiting no lymphotoxic properties. EFFECT: higher efficiency. 5 dwg, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
IMMUNOMODULATOR | 2018 |
|
RU2691143C1 |
IMMUNOMODULATOR | 2019 |
|
RU2702114C1 |
METHOD OF COLD-ASSISTED STIMULATION HUMORAL AND CELLULAR IMMUNITY | 1996 |
|
RU2142809C1 |
METHOD FOR SUPPRESSING HUMORAL AND CELLULAR IMMUNE RESPONSE | 1990 |
|
SU1748512A1 |
IMMUNOMODULATOR | 2003 |
|
RU2253444C1 |
METHOD FOR ASSESSMENT OF SPECIFIC LEVAMISOLE SENSITIVITY IN PATIENTS SUFFERED FROM RHEUMATIC ARTHRITIS | 1986 |
|
RU2014605C1 |
IMMUNOMODULATING AGENT | 2003 |
|
RU2245142C1 |
METHOD FOR TREATING SECONDARY IMMUNODEFICIENCY | 1994 |
|
RU2099051C1 |
METHOD OF ESTIMATING ANTI-ERGOTYPIC RESPONSE IN EXPERIMENT | 2009 |
|
RU2423079C1 |
METHOD OF EVALUATION OF B-LYMPHOCYTE PROLIFERATIVE ACTIVITY IN VITRO USING BIOFLAVANOID FROM THE ROSE ROOT | 1992 |
|
RU2088932C1 |
Authors
Dates
1998-04-10—Published
1993-03-31—Filed